Increased Levels of Circulating IL-16 and Apoptosis Markers Are Related to the Activity of Whipple's Disease
Open Access
- 6 June 2007
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 2 (6), e494
- https://doi.org/10.1371/journal.pone.0000494
Abstract
Whipple's disease (WD) is an infectious disease caused by Tropheryma whipplei, which replicates in macrophages and induces the release of interleukin (IL)-16, a substrate of caspase 3, and macrophage apoptosis. The disease is characterized by intestinal, cardiac or neurological manifestations; its diagnosis is based on invasive analysis requiring tissue biopsies or cerebrospinal fluid puncture. The disease progression is slow and often complicated by relapses despite empirical antibiotic treatment. We monitored circulating levels of IL-16 and nucleosomes in 36 French patients with WD; among them, some patients were enrolled in a longitudinal follow-up. As compared to control subjects, the circulating levels of both IL-16 and nucleosomes were increased in untreated patients with WD presenting as intestinal, cardiac or neurological manifestations. This finding was specific to WD since the circulating levels of IL-16 and nucleosomes were not increased in patients with unrelated inflammatory diseases such as inflammatory bowel disease or Q fever endocarditis. We also found that increased levels of IL-16 and nucleosomes were related to the activity of the disease. Indeed, successful antibiotic treatment decreased those levels down to those of control subjects. In contrast, patients who suffered from relapses exhibited circulating levels of IL-16 and nucleosomes as high as those of untreated patients. Circulating levels of both IL-16 and nucleosomes were increased in WD. This finding provides simple and non-invasive tools for the diagnosis and the prognosis of WD.Keywords
This publication has 43 references indexed in Scilit:
- Whipple's DiseaseNew England Journal of Medicine, 2007
- European evidence based consensus on the diagnosis and management of Crohn's disease: current managementGut, 2006
- Increased levels of bioactive IL-16 correlate with disease activity during relapsing experimental autoimmune encephalomyelitis (EAE)Journal of Autoimmunity, 2005
- Cardiac Valves in Patients with Whipple Endocarditis: Microbiological, Molecular, Quantitative Histologic, and Immunohistochemical Studies of 5 PatientsThe Journal of Infectious Diseases, 2004
- Whipple Disease Associated with GiardiasisThe Journal of Infectious Diseases, 2003
- Interleukin 16 expression and phenotype of interleukin 16 producing cells in Crohn's diseaseGut, 2001
- Increased expression of IL-16 in inflammatory bowel diseaseGut, 2001
- Whipple's DiseaseClinical and Diagnostic Laboratory Immunology, 2001
- Processing and Activation of Pro-Interleukin-16 by Caspase-3Journal of Biological Chemistry, 1998
- WHIPPLEʼS DISEASEMedicine, 1970